000 01385 a2200397 4500
005 20250513110141.0
264 0 _c19970117
008 199701s 0 0 eng d
022 _a0090-4295
024 7 _a10.1016/s0090-4295(96)00315-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOrnstein, D K
245 0 0 _aCombined finasteride and flutamide therapy in men with advanced prostate cancer.
_h[electronic resource]
260 _bUrology
_cDec 1996
300 _a901-5 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Agents, Hormonal
_xadministration & dosage
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aEnzyme Inhibitors
_xadministration & dosage
650 0 4 _aFinasteride
_xadministration & dosage
650 0 4 _aFlutamide
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Staging
650 0 4 _aProstate-Specific Antigen
_xblood
650 0 4 _aProstatic Neoplasms
_xblood
700 1 _aRao, G S
700 1 _aJohnson, B
700 1 _aCharlton, E T
700 1 _aAndriole, G L
773 0 _tUrology
_gvol. 48
_gno. 6
_gp. 901-5
856 4 0 _uhttps://doi.org/10.1016/s0090-4295(96)00315-9
_zAvailable from publisher's website
999 _c8965385
_d8965385